HEADER HYDROLASE INHIBITOR 29-DEC-16 5WVX TITLE CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE TITLE 2 INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN/CHYMOTRYPSIN INHIBITOR; COMPND 3 CHAIN: A, B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ALOCASIA MACRORRHIZOS; SOURCE 3 ORGANISM_COMMON: GIANT TARO; SOURCE 4 ORGANISM_TAXID: 4456 KEYWDS KUNITZ TYPE TRYPSIN INHIBITOR, ALPHA AMYLASE INHIBITOR, HYDROLASE KEYWDS 2 INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR M.PALAYAM,M.RADHAKRISHNAN,K.LAKSHMINARAYANAN,K.E.BALU,J.GANAPATHY, AUTHOR 2 G.KRISHNASAMY REVDAT 4 22-NOV-23 5WVX 1 HETSYN REVDAT 3 29-JUL-20 5WVX 1 COMPND REMARK HETNAM SITE REVDAT 2 24-JUN-20 5WVX 1 CAVEAT REVDAT 1 13-JUN-18 5WVX 0 JRNL AUTH M.PALAYAM,J.GANAPATHY,K.E.BALU,G.PENNATHUR,G.KRISHNASAMY JRNL TITL STRUCTURAL INSIGHTS INTO A MULTIFUNCTIONAL INHIBITOR, JRNL TITL 2 'AMTIN' FROM TUBERS OF ALOCASIA MACRORRHIZOS AND ITS JRNL TITL 3 POSSIBLE ROLE IN DENGUE PROTEASE (NS2B-NS3) INHIBITION. JRNL REF INT. J. BIOL. MACROMOL. V. 113 681 2018 JRNL REFN ISSN 1879-0003 JRNL PMID 29505868 JRNL DOI 10.1016/J.IJBIOMAC.2018.03.010 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 84.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 44.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.298 REMARK 3 R VALUE (WORKING SET) : 0.279 REMARK 3 FREE R VALUE : 0.311 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 817 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 59.6491 - 5.4614 0.90 1275 147 0.3193 0.3149 REMARK 3 2 5.4614 - 4.3353 0.90 1250 136 0.2731 0.2898 REMARK 3 3 4.3353 - 3.7874 0.90 1220 131 0.2821 0.2863 REMARK 3 4 3.7874 - 3.4411 0.90 1248 137 0.3055 0.3376 REMARK 3 5 3.4411 - 3.1945 0.90 1217 133 0.2976 0.3840 REMARK 3 6 3.1945 - 3.0062 0.89 1217 133 0.3002 0.3851 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2337 REMARK 3 ANGLE : 0.817 3173 REMARK 3 CHIRALITY : 0.049 361 REMARK 3 PLANARITY : 0.008 424 REMARK 3 DIHEDRAL : 7.198 1384 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WVX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1300002486. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : CUK REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8256 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.003 REMARK 200 RESOLUTION RANGE LOW (A) : 84.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.05494 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: 1AVA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE AND CITRATE, PH 4, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.99000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 14.49500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 43.48500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 26 REMARK 465 GLY A 27 REMARK 465 SER A 38 REMARK 465 GLU A 95 REMARK 465 ALA A 96 REMARK 465 GLY A 97 REMARK 465 PHE A 98 REMARK 465 VAL A 99 REMARK 465 THR A 100 REMARK 465 SER A 126 REMARK 465 GLN A 127 REMARK 465 PRO A 128 REMARK 465 ARG A 129 REMARK 465 ASP A 130 REMARK 465 GLY A 150 REMARK 465 CYS A 151 REMARK 465 LEU A 152 REMARK 465 THR A 175 REMARK 465 ILE A 176 REMARK 465 ARG A 177 REMARK 465 PHE A 178 REMARK 465 VAL A 179 REMARK 465 LYS A 180 REMARK 465 VAL A 181 REMARK 465 LYS A 182 REMARK 465 GLU A 183 REMARK 465 GLY A 184 REMARK 465 ARG B 25 REMARK 465 PRO B 26 REMARK 465 SER B 38 REMARK 465 PRO B 47 REMARK 465 PHE B 48 REMARK 465 ASP B 49 REMARK 465 GLU B 50 REMARK 465 ALA B 96 REMARK 465 GLY B 97 REMARK 465 PHE B 98 REMARK 465 VAL B 99 REMARK 465 THR B 100 REMARK 465 SER B 126 REMARK 465 GLN B 127 REMARK 465 PRO B 128 REMARK 465 ARG B 129 REMARK 465 ASP B 130 REMARK 465 THR B 140 REMARK 465 CYS B 151 REMARK 465 LEU B 152 REMARK 465 GLY B 153 REMARK 465 THR B 175 REMARK 465 ILE B 176 REMARK 465 ARG B 177 REMARK 465 PHE B 178 REMARK 465 VAL B 179 REMARK 465 LYS B 180 REMARK 465 VAL B 181 REMARK 465 LYS B 182 REMARK 465 GLU B 183 REMARK 465 GLY B 184 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 25 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 50 CG CD OE1 OE2 REMARK 470 TYR A 51 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 94 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 107 CG CD CE NZ REMARK 470 TYR A 131 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 143 CG CD OE1 OE2 REMARK 470 ASN A 163 CG OD1 ND2 REMARK 470 TYR B 51 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 94 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 95 CG CD OE1 OE2 REMARK 470 THR B 101 OG1 CG2 REMARK 470 LYS B 107 CB CG CD CE NZ REMARK 470 TYR B 131 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 148 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 ASN B 163 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 139 C5 NGA A 201 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 2 75.76 -156.67 REMARK 500 MET A 24 -122.34 -88.00 REMARK 500 LYS A 36 -77.35 57.51 REMARK 500 PRO A 40 111.16 -31.38 REMARK 500 PRO A 47 -75.28 -82.05 REMARK 500 PHE A 48 -164.74 -72.68 REMARK 500 ASP A 64 -127.95 -152.42 REMARK 500 PRO A 79 48.15 -72.43 REMARK 500 SER A 106 21.17 -172.62 REMARK 500 PRO A 111 41.45 -96.89 REMARK 500 HIS A 112 -146.07 -103.81 REMARK 500 SER A 114 -165.56 -69.47 REMARK 500 ARG A 115 80.81 60.13 REMARK 500 PHE A 116 81.09 -161.32 REMARK 500 ALA A 117 60.37 -62.99 REMARK 500 ILE A 118 -20.49 -146.55 REMARK 500 ALA A 124 -166.98 -72.25 REMARK 500 GLN A 132 -119.46 -177.01 REMARK 500 PRO A 137 81.87 -69.75 REMARK 500 SER A 139 -57.00 -137.49 REMARK 500 GLU A 143 -147.11 -155.72 REMARK 500 ARG A 144 98.98 -175.80 REMARK 500 ARG A 148 -78.11 -60.61 REMARK 500 GLU A 159 -98.25 -133.35 REMARK 500 PRO B 35 -143.50 -65.07 REMARK 500 ASP B 64 -121.54 -139.28 REMARK 500 PRO B 79 59.38 -67.38 REMARK 500 THR B 88 22.71 -79.26 REMARK 500 THR B 104 -145.44 -112.89 REMARK 500 THR B 105 46.14 -148.33 REMARK 500 LYS B 107 94.37 -48.82 REMARK 500 ASN B 113 -161.26 -71.43 REMARK 500 SER B 114 -172.16 -63.54 REMARK 500 ARG B 115 71.94 62.45 REMARK 500 ALA B 117 34.98 -77.78 REMARK 500 GLN B 132 -91.28 -114.20 REMARK 500 GLU B 143 -164.06 -164.82 REMARK 500 LEU B 157 -147.58 -76.48 REMARK 500 ASN B 163 71.90 -109.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 39 PRO A 40 -149.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AVA RELATED DB: PDB DBREF 5WVX A 1 184 UNP P35812 ITC_ALOMA 1 184 DBREF 5WVX B 1 184 UNP P35812 ITC_ALOMA 1 184 SEQRES 1 A 184 THR ASN PRO VAL LEU ASP VAL ASP GLY ASN GLU LEU GLN SEQRES 2 A 184 ARG GLY GLN LEU TYR TYR ALA THR SER VAL MET ARG PRO SEQRES 3 A 184 GLY GLY GLY LEU THR LEU ALA ALA PRO LYS GLY SER CYS SEQRES 4 A 184 PRO LEU ASN VAL ALA GLN ALA PRO PHE ASP GLU TYR SER SEQRES 5 A 184 GLY ARG PRO LEU ALA PHE PHE PRO GLU ASN ALA ASP ASP SEQRES 6 A 184 ASP THR VAL GLN GLU GLY SER THR LEU TYR ILE MET PHE SEQRES 7 A 184 PRO GLU PRO THR ARG CYS PRO GLN SER THR VAL TRP THR SEQRES 8 A 184 PHE ASP ARG GLU ALA GLY PHE VAL THR THR GLY GLY THR SEQRES 9 A 184 THR SER LYS ALA ILE GLY PRO HIS ASN SER ARG PHE ALA SEQRES 10 A 184 ILE ARG LYS ALA GLY ASP ALA SER SER GLN PRO ARG ASP SEQRES 11 A 184 TYR GLN ILE GLU VAL CYS PRO CYS SER THR GLY VAL GLU SEQRES 12 A 184 ARG PRO SER CYS ARG MET GLY CYS LEU GLY THR LEU GLY SEQRES 13 A 184 LEU ALA GLU GLY GLY LYS ASN VAL LEU LEU ASN ILE ASN SEQRES 14 A 184 ASN GLU SER PRO HIS THR ILE ARG PHE VAL LYS VAL LYS SEQRES 15 A 184 GLU GLY SEQRES 1 B 184 THR ASN PRO VAL LEU ASP VAL ASP GLY ASN GLU LEU GLN SEQRES 2 B 184 ARG GLY GLN LEU TYR TYR ALA THR SER VAL MET ARG PRO SEQRES 3 B 184 GLY GLY GLY LEU THR LEU ALA ALA PRO LYS GLY SER CYS SEQRES 4 B 184 PRO LEU ASN VAL ALA GLN ALA PRO PHE ASP GLU TYR SER SEQRES 5 B 184 GLY ARG PRO LEU ALA PHE PHE PRO GLU ASN ALA ASP ASP SEQRES 6 B 184 ASP THR VAL GLN GLU GLY SER THR LEU TYR ILE MET PHE SEQRES 7 B 184 PRO GLU PRO THR ARG CYS PRO GLN SER THR VAL TRP THR SEQRES 8 B 184 PHE ASP ARG GLU ALA GLY PHE VAL THR THR GLY GLY THR SEQRES 9 B 184 THR SER LYS ALA ILE GLY PRO HIS ASN SER ARG PHE ALA SEQRES 10 B 184 ILE ARG LYS ALA GLY ASP ALA SER SER GLN PRO ARG ASP SEQRES 11 B 184 TYR GLN ILE GLU VAL CYS PRO CYS SER THR GLY VAL GLU SEQRES 12 B 184 ARG PRO SER CYS ARG MET GLY CYS LEU GLY THR LEU GLY SEQRES 13 B 184 LEU ALA GLU GLY GLY LYS ASN VAL LEU LEU ASN ILE ASN SEQRES 14 B 184 ASN GLU SER PRO HIS THR ILE ARG PHE VAL LYS VAL LYS SEQRES 15 B 184 GLU GLY HET NGA A 201 14 HET CIT A 202 13 HET NGA B 201 14 HET CIT B 202 13 HETNAM NGA 2-ACETAMIDO-2-DEOXY-BETA-D-GALACTOPYRANOSE HETNAM CIT CITRIC ACID HETSYN NGA N-ACETYL-BETA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NGA BETA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2- HETSYN 3 NGA ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-D-GALACTOSAMINE FORMUL 3 NGA 2(C8 H15 N O6) FORMUL 4 CIT 2(C6 H8 O7) SHEET 1 AA1 2 LEU A 12 GLN A 13 0 SHEET 2 AA1 2 THR A 67 VAL A 68 -1 O VAL A 68 N LEU A 12 SHEET 1 AA2 4 LEU A 74 MET A 77 0 SHEET 2 AA2 4 PRO A 55 PRO A 60 -1 N PHE A 59 O TYR A 75 SHEET 3 AA2 4 LEU A 17 SER A 22 -1 N TYR A 18 O LEU A 56 SHEET 4 AA2 4 ASN A 167 GLU A 171 -1 O ILE A 168 N THR A 21 SHEET 1 AA3 2 LEU A 30 ALA A 33 0 SHEET 2 AA3 2 ASN A 42 GLN A 45 -1 O ALA A 44 N THR A 31 SHEET 1 AA4 2 TRP A 90 PHE A 92 0 SHEET 2 AA4 2 GLY A 103 THR A 105 -1 O THR A 104 N THR A 91 SHEET 1 AA5 2 GLY A 122 ALA A 124 0 SHEET 2 AA5 2 ILE A 133 VAL A 135 -1 O GLU A 134 N ASP A 123 SHEET 1 AA6 2 TYR B 18 THR B 21 0 SHEET 2 AA6 2 ILE B 168 GLU B 171 -1 O ASN B 170 N TYR B 19 SHEET 1 AA7 2 LEU B 30 ALA B 33 0 SHEET 2 AA7 2 ASN B 42 GLN B 45 -1 O ASN B 42 N ALA B 33 SHEET 1 AA8 2 ALA B 57 PRO B 60 0 SHEET 2 AA8 2 LEU B 74 MET B 77 -1 O TYR B 75 N PHE B 59 SHEET 1 AA9 2 THR B 91 PHE B 92 0 SHEET 2 AA9 2 GLY B 103 THR B 104 -1 O THR B 104 N THR B 91 SHEET 1 AB1 2 LYS B 120 ALA B 124 0 SHEET 2 AB1 2 ILE B 133 PRO B 137 -1 O GLU B 134 N ASP B 123 SHEET 1 AB2 2 ARG B 144 CYS B 147 0 SHEET 2 AB2 2 ALA B 158 GLY B 161 -1 O GLU B 159 N SER B 146 SSBOND 1 CYS A 39 CYS A 84 1555 1555 2.03 SSBOND 2 CYS B 39 CYS B 84 1555 1555 2.03 LINK OG SER A 139 C6 NGA A 201 1555 1555 1.37 LINK OG SER B 139 C6 NGA B 201 1555 1555 1.38 CISPEP 1 CYS B 39 PRO B 40 0 3.07 CRYST1 84.340 84.340 57.980 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011857 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011857 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017247 0.00000